Piazza et al. discovered SETBP1 mutations in 24% of aCML, 10% of unclassified MDS/MPN, 4% of CMML and in 25% of CNL cases [15]. Here, SETBP1 is linked to atypical chronic myeloid leukemia, BCR-ABL1 negative.